Earnings Watch

BIG PHARMA EARNINGS WATCH: PFIZER, MODERNA, ELI LILLY, NOVARTIS, GLAXOSMITHKLINE, ROCHE, AMGEN

May 9, 2023

Brand Name Drug Companies Continue to Hike Prices and Post Record Profits Read More

BIG PHARMA EARNINGS WATCH: MERCK, SANOFI, BRISTOL MYERS SQUIBB, ABBVIE AND ASTRAZENECA

May 3, 2023

More Big Pharma Giants Surpass Wall Street Expectations, Buoyed By Egregious Read More

BIG PHARMA EARNINGS WATCH: JOHNSON & JOHNSON

Apr 24, 2023

Big Pharma Giant Kicks Off Q1 Earnings By Boasting “Strategic Price Read More

BIG PHARMA EARNINGS WATCH: ABBVIE AND ASTRAZENECA

Feb 28, 2023

Big Pharma Giants Once Again Top Wall Street Expectations in Final Round of Read More

BIG PHARMA EARNINGS WATCH: MERCK, SANOFI, BRISTOL-MYERS SQUIBB AND ELI LILLY

Feb 21, 2023

Four Big Pharma Giants That Hiked Drug Prices on American Patients in 2022 and Read More

BIG PHARMA EARNINGS WATCH: PFIZER, AMGEN, GLAXOSMITHKLINE, NOVARTIS AND JOHNSON & JOHNSON

Feb 6, 2023

Brand Name Drug Companies Kick Off Q4 Earnings Calls After More than 600 Price Read More

BIG PHARMA EARNINGS WATCH: GLAXOSMITHKLINE, AMGEN, ASTRAZENECA

Nov 11, 2022

Big Pharma Giants Notch Expectation-Busting Earnings After Continuing to Hike Read More

BIG PHARMA EARNINGS WATCH: PFIZER, ABBVIE, SANOFI, ELI LILLY

Nov 4, 2022

Big Pharma Giants Beat Wall Street Expectations After Year of Price Increases, Read More

BIG PHARMA EARNINGS WATCH: MERCK, BRISTOL MYERS SQUIBB, NOVARTIS

Oct 28, 2022

New Earnings Reports Show Big Pharma Giants Basking in Massive Profits, Read More

BIG PHARMA EARNINGS WATCH: JOHNSON & JOHNSON

Oct 19, 2022

J&J Beats Q3 Earnings Expectations After Dozens of Prescription Drug Price Read More

BIG PHARMA EARNINGS WATCH: ABBVIE, ASTRAZENECA, AMGEN

Aug 5, 2022

Big Pharma Drugmakers Top Wall Street Estimates After Hiking Drug Prices Read More

BIG PHARMA EARNINGS WATCH: PFIZER, MERCK, BRISTOL MYERS SQUIBB, GLAXOSMITHKLINE AND SANOFI

Jul 29, 2022

Big Pharma Giants All Top Analysts’ Expectations as Pharmaceutical Industry Read More